Eikon Therapeutics, Inc. Common Stock (EIKN) is a publicly traded the market company. As of July 27, 2026, EIKN trades at $8.91 with a market cap of $481.83M and a P/E ratio of -3.62. EIKN moved +0.06% today. Year to date, EIKN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $7.90 to $17.40. Analyst consensus is buy with an average price target of $18.50. Rallies surfaces EIKN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for EIKN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $8.91 |
| Market Cap | $481.83M |
| P/E Ratio | -3.62 |
| EPS | $-2.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.40 |
| 52-Week Low | $7.90 |
| Volume | 50 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.38M |
| Net Income | $-82.96M |
| Gross Margin | 0.00% |
3 analysts cover EIKN: 0 strong buy, 2 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $18.50.